$PCRX Pacira BioSciences, Inc. Insider Trading Week 23/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Pacira BioSciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Pacira BioSciences, Inc. in week 23/2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | A | 38.35 | 25,000 | 958,750 | 25,000 | |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Grant | A | 0.00 | 2,500 | 0 | 12,141 | 9.6 K to 12.1 K (+25.93 %) |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Reinhart Charles A. III | Chief Financial Off ... | Option Exercise | A | 38.35 | 30,000 | 1,150,500 | 30,000 | |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Reinhart Charles A. III | Chief Financial Off ... | Grant | A | 0.00 | 5,000 | 0 | 13,042 | 8 K to 13 K (+62.17 %) |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Option Exercise | A | 38.35 | 30,000 | 1,150,500 | 30,000 | |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | LARANJEIRA CHARLES ANTHONY | SVP, Technical Oper ... | Grant | A | 0.00 | 5,000 | 0 | 5,238 | 238 to 5.2 K (+2,100.84 %) |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Option Exercise | A | 38.35 | 4,693 | 179,977 | 4,693 | |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Grant | A | 0.00 | 782 | 0 | 24,319 | 23.5 K to 24.3 K (+3.32 %) |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | LONGENECKER JOHN P PHD | Director | Option Exercise | A | 38.35 | 4,693 | 179,977 | 4,693 | |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | LONGENECKER JOHN P PHD | Director | Grant | A | 0.00 | 782 | 0 | 5,927 | 5.1 K to 5.9 K (+15.20 %) |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Option Exercise | A | 38.35 | 4,693 | 179,977 | 4,693 | |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Grant | A | 0.00 | 782 | 0 | 7,577 | 6.8 K to 7.6 K (+11.51 %) |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Option Exercise | A | 38.35 | 4,693 | 179,977 | 4,693 | |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Grant | A | 0.00 | 782 | 0 | 3,529 | 2.7 K to 3.5 K (+28.47 %) |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Greenstreet Yvonne | Director | Option Exercise | A | 38.35 | 4,693 | 179,977 | 4,693 | |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Greenstreet Yvonne | Director | Grant | A | 0.00 | 782 | 0 | 5,627 | 4.8 K to 5.6 K (+16.14 %) |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Froimson Mark | Director | Option Exercise | A | 38.35 | 4,693 | 179,977 | 4,693 | |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Froimson Mark | Director | Grant | A | 0.00 | 782 | 0 | 882 | 100 to 882 (+782.00 %) |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Option Exercise | A | 38.35 | 4,693 | 179,977 | 4,693 | |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Grant | A | 0.00 | 782 | 0 | 4,627 | 3.8 K to 4.6 K (+20.34 %) |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Option Exercise | A | 38.35 | 47,250 | 1,812,038 | 47,250 | |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Grant | A | 0.00 | 7,875 | 0 | 27,147 | 19.3 K to 27.1 K (+40.86 %) |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Option Exercise | A | 38.35 | 170,250 | 6,529,088 | 170,250 | |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Grant | A | 0.00 | 28,375 | 0 | 110,415 | 82 K to 110.4 K (+34.59 %) |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Scranton Richard | Chief Scientific Of ... | Option Exercise | A | 38.35 | 47,250 | 1,812,038 | 47,250 | |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Scranton Richard | Chief Scientific Of ... | Grant | A | 0.00 | 7,875 | 0 | 20,101 | 12.2 K to 20.1 K (+64.41 %) |